Willis AW, Roberts E, Beck JC, Fiske B, Ross W, Savica R, et al
the Unordered Merchandise Statute, 39 U.S.C
How do you think about, knowing that we don't have the results of it yet, a trial structured in this manner with this kind of a composite endpoint
Most findings to date stem from pilot studies with limited replication across independent cohorts
On the other hand, no case report describing medullary thyroid carcinoma has been published in a patient being treated with a GLP-1 receptor agonist who had a morphologically normal thyroid and low calcitonin concentrations before such treatment
hazard ratios 1.54-1.95) Masseter domain patients saw their mean duration fall from ~20.1 2.9 weeks in controls to 17.3, 17.0, 16.7 and 16.2 weeks (hazard ratios 1.72-2.08) Sensitivity analysis suggested ~55% of the reduction in duration was attributable to synaptic modulation, ~30% to lean-mass decline, and ~15% to metabolic variability
